Influence of pharmacist intervention on prescribing of angiotensin-converting-enzyme inhibitors, angiotensin II-receptor blockers, and aspirin for diabetic patients

American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
Brandon LaMarrMary Ryan

Abstract

The influence of pharmacist intervention on the prescribing of angiotensin-converting-enzyme (ACE) inhibitors, angiotensin II-receptor blockers (ARBs), and aspirin for patients with diabetes was evaluated. A retrospective chart review was performed for diabetic patients seen in a family medicine clinic. Patients were included in the analyses if they were 18-88 years old, had a diagnosis of type 1 or type 2 diabetes, had been seen in the family medicine clinic between July 2006 and October 2008, and had received a consultation by pharmacy services. All selected charts were reviewed to assess appropriate use of ACE inhibitor, ARB, and aspirin therapy, as recommended by American Diabetes Association (ADA) guidelines, before and after pharmacist intervention. Typical pharmacist interventions consisted of direct consultation with the prescriber and therapeutic education sessions conducted by pharmacy personnel. All patients were seen and evaluated by pharmacy personnel before meeting with the prescriber. Before pharmacist intervention, 41 (59%) of 70 patients were receiving appropriate ACE inhibitor or ARB therapy and 24 (34%) of 71 patients were receiving appropriate aspirin therapy as recommended by ADA. After pharmacist intervent...Continue Reading

References

Sep 24, 2002·The Annals of Pharmacotherapy·Steven L Clause, Robert A Hamilton
Jan 14, 2003·Pharmacotherapy·John J FaragonHedy Migden
Feb 26, 2005·Journal of the American Pharmacists Association : JAPhA·Stephanie A HaggertyJohn J Faragon
Jan 25, 2007·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Miranda R Andrus, Deidre B Clark
Jul 28, 2007·American Journal of Medical Quality : the Official Journal of the American College of Medical Quality·Prasuna JamiBernardo J Reyes
Jan 10, 2008·Diabetes Care·UNKNOWN American Diabetes Association
Apr 5, 2008·Clinical Pharmacology and Therapeutics·L DolovichC Sellors
Jan 6, 2009·Diabetes Care·UNKNOWN American Diabetes Association

❮ Previous
Next ❯

Citations

Sep 29, 2011·International Journal of Clinical Pharmacy·Amir H ZargarzadehFadi T Khasawneh
Jan 31, 2016·International Journal of Clinical Pharmacy·Ines Krass
Oct 8, 2014·The Annals of Pharmacotherapy·Elaine W Fosmire RundgrenJoel C Marrs
Jan 1, 2016·American Journal of Therapeutics·Kira B Harris, Jacqueline L Olin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

© 2021 Meta ULC. All rights reserved